„reprogramming“
Suchergebnisse
2.540 Treffer
-
Prostate cancer exploits BRD9-driven metabolic reprogramming to shape the aggressive phenotype
-
Turn cold tumors hot by reprogramming the tumor microenvironment
-
Mapping the landscape of metabolic reprogramming research in lung cancer: a bibliometric and visualized analysis
-
NCAPH promotes glucose metabolism reprogramming and cell stemness in ovarian cancer cells through the MEK/ERK/PD-L1 pathway
-
Temozolomide promotes glioblastoma stemness expression through senescence-associated reprogramming via HIF1α/HIF2α regulation
-
The pathogenesis and therapeutic implications of metabolic reprogramming in renal cell carcinoma
-
Direct Neural Reprogramming in situ: Existing Approaches and Their Optimization
-
Endoplasmic reticulum stress related super-enhancers suppress cuproptosis via glycolysis reprogramming in lung adenocarcinoma
-
The glucose metabolism reprogramming of yak Sertoli cells under hypoxia is regulated by autophagy
-
RNF126 Promotes Ovarian Cancer Progression by Reprogramming Lipid Metabolism Through Degradation of ACAP2
-
The role of PKM2-mediated metabolic reprogramming in the osteogenic differentiation of BMSCs under diabetic periodontitis conditions
-
Chemical reprogramming culture for the expansion of salivary gland epithelial basal progenitor cells
-
Improving chemical reprogramming strategies
-
In vitro study on the promotion of osteogenic differentiation by mitochondrial-derived vesicles through activation of inflammation and reprogramming of metabolic pathways
-
IGF2BP3/ESM1/KLF10/BECN1 positive feedback loop: a novel therapeutic target in ovarian cancer via lipid metabolism reprogramming
-
Reprogramming the tumor immune microenvironment to treat glioblastoma
-
Phosphorylation of PFKL regulates metabolic reprogramming in macrophages following pattern recognition receptor activation
-
Evidence for conserved DNA and histone H3 methylation reprogramming in mouse, bovine and rabbit zygotes
-
Metabolic Reprogramming in Spinal Cord Injury and Analysis of Potential Therapeutic Targets
-
C12ORF49 inhibits ferroptosis in hepatocellular carcinoma cells via reprogramming SREBP1/SCD1-mediated lipid metabolism